March 11th, 2013
Devices vs. Drugs: A Distinction Without a Difference? Blogging from ACC.13
Sandeep Mangalmurti, MD, JD
How are devices regulated? Due to some quirks, the tail now wags the dog.
March 10th, 2013
You Are My Sunshine: Blogging from ACC.13
Sandeep Mangalmurti, MD, JD
“It is difficult to get a man to understand something, when his salary depends upon his not understanding it.”
October 3rd, 2012
ACC Fellows in Training Push Congress for Sustainable Health Care Reform
Michael Tempelhof, MD MSc
Dr. Michael Tempelhof, one of the ACC’s Fellows in Training, discusses the group’s efforts to lobby Congress for a restructured health care program, emphasizing high-quality, evidence-based medicine.
August 7th, 2012
Reducing MI Readmissions: Time to Turn Objectives into Practice
Betsy Bradley, Ph.D.
A survey finds that while most hospitals have a stated objective to reduce AMI readmissions, adoption of actual strategies to achieve that goal is another matter.
August 6th, 2012
TAVR and the Price of Innovation
Daniel Mark, Richard A. Lange, MD, MBA and L. David Hillis, MD
In an article published in Circulation, Daniel Mark and Robert Mentz of the Duke Clinical Research Institute and University Medical Center examine the economic and policy implications of the recent validation of transcatheter aortic valve replacement (TAVR) in the PARTNER trials. CardioExchange is fortunate and pleased to present Dr. Mark’s responses to questions about his […]
June 29th, 2012
What Does the Supreme Court’s Upholding of Healthcare Reform Mean for Doctors and Patients?
CardioExchange Editors, Staff
Weigh in on what the SCOTUS/ACA decision means to you, your patients, and your family
February 2nd, 2012
The Biggest Opportunities for Cost Savings in Cardiology: Take II
Harlan M. Krumholz, MD, SM
Let’s build on the suggestions that the community has made. How do we actually deliver on some on reducing these tests and procedures? What are we still missing?
January 9th, 2012
What Are the Biggest Opportunities for Cost Savings in Cardiology?
Harlan M. Krumholz, MD, SM
Tell us the one test or procedure that you think should be carefully examined to make the biggest dent on waste in cardiac care.
NEJM Journal Watch — Recent Cardiology Articles- More Data on Finerenone for Heart Failure with Preserved or Mildly Reduced Ejection Fraction
- Cardiovascular Outcomes of Tirzepatide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long Is Long Enough?